Related Experiment Video
Updated: Dec 20, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Patterns of clinical presentation in Takayasu's arteritis
Kaitlin A Quinn1, K Bates Gribbons2, Simon Carette3
1Division of Rheumatology, MedStar Georgetown University Hospital, Washington DC, USA; Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD, USA.
Takayasu's arteritis presents diversely at diagnosis, challenging the traditional triphasic disease model. Understanding these varied presentations is key for effective Takayasu's arteritis management.
Area of Science:
- Rheumatology
- Immunology
- Vascular Medicine
Background:
- Takayasu's arteritis (TAK) is a rare, chronic inflammatory condition affecting large arteries.
- The typical disease progression, a "triphasic pattern," lacks systematic evaluation.
- Clinical heterogeneity at diagnosis is recognized but not well-characterized.
Purpose of the Study:
- To systematically evaluate the patterns of clinical presentation in Takayasu's arteritis at diagnosis.
- To assess the validity of a proposed "triphasic pattern" of disease progression.
Main Methods:
- Prospective recruitment of 275 Takayasu's arteritis patients from NIH and VCRC.
- Categorization of patients based on diagnosis presentation: constitutional, carotidynia, vascular, ischemic event, or asymptomatic.
- Assessment of clinical characteristics and preceding symptoms for triphasic pattern identification.
Main Results:
- Diverse presentations observed: constitutional (8%), carotidynia (13-15%), vascular symptoms (43-47%), ischemic event (28-30%), asymptomatic (2-6%).
- Younger patients presented with constitutional symptoms or ischemic events; older patients were asymptomatic.
- Relapse rates were highest in carotidynia cases; only 19% with ischemic events reported a triphasic pattern.
Conclusions:
- Takayasu's arteritis exhibits significant clinical heterogeneity at diagnosis.
- Patients do not consistently follow a sequential triphasic disease progression.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

